NCT00424671View on ClinicalTrials.gov

Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of Licarbazepine

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

Licarbazepine

Trial Locations (1)

Unknown

Novartis Investigative site, Prague

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY